Health Now
Live

Lung cancer

Lung cancer is a malignant tumor that originates in the tissues of the lungs. Lung cancer is caused by genetic damage to the DNA of cells in the airways, often caused by cigarette smoking or inhaling damaging chemicals. Damaged airway cells gain the ability to multiply unchecked, causing the growth of a tumor. Without treatment, tumors spread throughout the lung, damaging lung function. Eventually lung tumors metastasize, spreading to other parts of the body.

Read more on Wikipedia →

2,320trials recruiting now
Chinamost trial sites (791)
400+mapped site locations
Memorial Sloan Ketterimost active sponsor

Breakdowns below use the 2,000 most relevant recruiting trials.

Trials by phase

  • Early phase 117
  • Phase 1479
  • Phase 2724
  • Phase 3180
  • Phase 417
  • Not applicable (device/behavioral)378
  • Observational study462

Phase 1 tests safety, phase 2 tests whether it works, phase 3 compares it with standard care, phase 4 follows it after approval.

Countries with the most trials

  • China791
  • United States768
  • France214
  • Spain189
  • Italy180
  • Australia136
  • South Korea135
  • United Kingdom130

Where trials are recruiting

Each dot is a site city; bigger dots have more recruiting trials. Showing up to 400 locations.

Lead sponsors

Memorial Sloan Kettering Cancer Center · 29M.D. Anderson Cancer Center · 28National Cancer Institute (NCI) · 27AstraZeneca · 27Fudan University · 27Shanghai Chest Hospital · 26Shanghai Pulmonary Hospital, Shanghai, China · 26Sun Yat-sen University · 25

Newest recruiting trials

See all 2,320 on ClinicalTrials.gov →

General information only, not medical advice. Trial listings are written by sponsors; eligibility and contacts are on each official listing.